HCID 59627090, Verbindung → HCID 59627097, Verbindung
Reaktionsgleichung
Br[C:2]1[CH:7]=[C:6]([S:8]([C:11]2[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=2)(=[O:10])=[O:9])[CH:5]=[CH:4][C:3]=1[N+:17]([O-:19])=[O:18].[C:20]([O:24][C:25]([NH:27][C@H:28]([C:46]([O:48][CH3:49])=[O:47])[CH2:29]C1C([N+]([O-])=O)=NC=C(OC2C=CC=CC=2)C=1)=[O:26])([CH3:23])([CH3:22])[CH3:21]>>[C:20]([O:24][C:25]([NH:27][C@H:28]([C:46]([O:48][CH3:49])=[O:47])[CH2:29][C:2]1[CH:7]=[C:6]([S:8]([C:11]2[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=2)(=[O:10])=[O:9])[CH:5]=[CH:4][C:3]=1[N+:17]([O-:19])=[O:18])=[O:26])([CH3:23])([CH3:21])[CH3:22]Komponenten
3
Versuchsvorschrift
Methyl N-(tert-butoxycarbonyl)-2-nitro-5-(phenylsulfonyl)-L-phenylalaninate (70) Compound 70 was prepared from 2-bromo-1-nitro-4-(phenylsulfonyl)benzene (69) according to the general procedure for the synthesis of methyl N-(tert-butoxycarbonyl)-3-(2-nitro-5-phenoxypyridin-3-yl)-L-alaninate (65) in Example 66. The product was obtained as an off-white foam (250 mg, 37%). LCMS m/z 463.1 (M−1).
Quellen und Nachweise
- ORD-Eintrag
- ord-e07d6937b7f84ef6bb99876531bb2217
- Quelldatensatz
- uspto-grants-2012_05